Acanya
NDC Package 13548-1321-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Acanya is this combination medication is used to treat a certain type of acne (inflammatory acne vulgaris). Marketed by Coria Laboratories, this product is identified by NDC 13548-1321 and is authorized under FDA application NDA050819.

Identification & Billing

NDC Package Code
13548-1321-5
Package Description
1 BOTTLE, PUMP in 1 CARTON / 50 g in 1 BOTTLE, PUMP
Product Code
13548-1321
11-Digit Billing Format
13548132105

Clinical Specifications

Proprietary Name
Acanya
Dosage Form
-
Usage Information
This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris). It helps to decrease the number of acne pimples. Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin, helping keep your pores open.

Regulatory & Marketing

Labeler Name
Coria Laboratories
FDA Application #
NDA050819
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-26-2010
End Marketing Date
05-28-2010
Listing Expiration
05-28-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13548-1321-5 identifies a specific commercial package of 1 bottle, pump in 1 carton / 50 g in 1 bottle, pump of Acanya, labeled by Coria Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Coria Laboratories on July 26, 2010. The current certification is valid through May 28, 2010.

What are the primary indications for this medication?

This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris). It helps to decrease the number of acne pimples. Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin, helping keep your pores open.

How is this Coria Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13548132105. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
13548-1321-5
11-Digit CMS (5-4-2)
13548-1321-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.